Showing results (51-60 of 97) with videos related to
Sort By:
Pageof 10
JTO Clinical and Research Reports|November 8, 2021
Abemaciclib in Combination With Pembrolizumab for Stage IV KRAS-Mutant or Squamous NSCLC: A Phase 1b StudyJean-Louis Pujol, Johan Vansteenkiste, Luis Paz-Ares Rodríguez, et al.European Journal of Internal Medicine|July 12, 2022
Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitorsCorrado Campochiaro, Nicola Farina, Alessandro Tomelleri, et al.Oncotarget|September 17, 2017
A phase 1 dose-escalation study of the oral histone deacetylase inhibitor abexinostat in combination with standard hypofractionated radiotherapy in advanced solid tumorsEric Deutsch, Elizabeth Cohen-Jonathan Moyal, Vanesa Gregorc, et al.International Journal of Dermatology|July 30, 2020
Clinicopathological and dermoscopic features of amelanotic and hypomelanotic melanoma: a retrospective multicentric studyGiovanni Paolino, Pietro Bearzi, Riccardo Pampena, et al.Lung Cancer (Amsterdam, Netherlands)|July 20, 2019
Identification and monitoring of somatic mutations in circulating cell-free tumor DNA in lung cancer patientsIlaria Francaviglia, Gilda Magliacane, Chiara Lazzari, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 4, 2011
Changes in plasma mass-spectral profile in course of treatment of non-small cell lung cancer patients with epidermal growth factor receptor tyrosine kinase inhibitorsChiara Lazzari, Anna Spreafico, Angela Bachi, et al.Cancers|September 15, 2020
Uncommon Site of Metastasis and Prolonged Survival in Patients with Anaplastic Thyroid Carcinoma: A Systematic Review of the LiteratureAurora Mirabile, Matteo Biafora, Leone Giordano, et al.Investigational New Drugs|April 5, 2020
A randomized, phase 2 study of deoxyuridine triphosphatase inhibitor, TAS-114, in combination with S-1 versus S-1 alone in patients with advanced non-small-cell lung cancerNobuyuki Yamamoto, Hidetoshi Hayashi, David Planchard, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Effects of gefitinib on serum epidermal growth factor receptor and HER2 in patients with advanced non-small cell lung cancerVanesa Gregorc, Giovanni Luca Ceresoli, Irene Floriani, et al.Cells|May 16, 2023
Gene Fusion Detection in NSCLC Routine Clinical Practice: Targeted-NGS or FISH?Lorenza Pecciarini, Emanuela Brunetto, Greta Grassini, et al.Pageof 10